is tirzepatide a glp-1 or glp 2 medication may be most effective for weight loss Beyond glycemia: Comparing tirzepatide to

Most patients experience peak nausea within the first 3-5 days after injection, with significant improvement by week 3-4 as their body adapts to the medication

Treatment should be discontinued if patients do not achieve at least 5% weight loss after 6 months (semaglutide) or 12 weeks (liraglutide)

Serious adverse events in trials remain rare and comparable to placebo rates when adjusted for study populations

Please Note: You are also required to complete a form at checkout

Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S

Pre-treatment preparation (weeks 1 through 2 before starting) Take comprehensive baseline measurements and photos